Cargando…

Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysis

BACKGROUND: Hepatitis C virus (HCV) is one of the major public health problems both in developed and developing countries. Prison represents a high-risk environment for prisoners, in that it is characterized by high-risk behaviors such as injecting drug use (IDU), tattooing, unprotected sexual inter...

Descripción completa

Detalles Bibliográficos
Autores principales: Behzadifar, Masoud, Gorji, Hasan Abolghasem, Rezapour, Aziz, Bragazzi, Nicola Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941323/
https://www.ncbi.nlm.nih.gov/pubmed/29739400
http://dx.doi.org/10.1186/s12954-018-0231-0
_version_ 1783321263375122432
author Behzadifar, Masoud
Gorji, Hasan Abolghasem
Rezapour, Aziz
Bragazzi, Nicola Luigi
author_facet Behzadifar, Masoud
Gorji, Hasan Abolghasem
Rezapour, Aziz
Bragazzi, Nicola Luigi
author_sort Behzadifar, Masoud
collection PubMed
description BACKGROUND: Hepatitis C virus (HCV) is one of the major public health problems both in developed and developing countries. Prison represents a high-risk environment for prisoners, in that it is characterized by high-risk behaviors such as injecting drug use (IDU), tattooing, unprotected sexual intercourses, or sharing syringes. The aim of this study was to quantitatively evaluate the prevalence of HCV among Iranian prisoners conducting a systematic review and meta-analysis. METHODS: We searched different scholarly databases including Embase, PubMed/MEDLINE, ISI/Web of Sciences, the Cochrane library, Scopus, CINAHL, and PsycINFO as well as Iranian bibliographic thesauri (namely, Barakatns, MagIran, and SID) up to December 2017. The Newcastle Ottawa Scale (NOS) was used to assess the quality of the studies included. HCV prevalence rate with its 95% confidence interval (CI) was estimated using the DerSimonian-Laird random-effects model, with Freeman-Tukey double arcsine transformation. Egger’s regression test was used to evaluate publication bias. RESULTS: Finally, 17 articles were selected based on inclusion and exclusion criteria. Overall, 18,693 prisoners were tested. Based on the random-effects model, the prevalence of HCV among Iranian prisoners was 28% (CI 95% 21–36) with heterogeneity of I(2) = 99.3% (p = 0.00). All studies used an ELISA test for the evaluation of HCV antibodies. The findings of this study showed that the highest prevalence rate (53%) was among prisoners who inject drugs. CONCLUSION: The findings of our study showed that the prevalence of HCV among Iranian prisoners is dramatically high. Managing this issue in Iran’s prisons requires careful attention to the availability of health facilities and instruments, such as screening, and harm reduction policies, such as giving sterile syringes and needles to prisoners. An integrated program of training for prisoners, prison personnel and medical staff is also needed to improve the level of health condition in prisons.
format Online
Article
Text
id pubmed-5941323
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59413232018-05-11 Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysis Behzadifar, Masoud Gorji, Hasan Abolghasem Rezapour, Aziz Bragazzi, Nicola Luigi Harm Reduct J Review BACKGROUND: Hepatitis C virus (HCV) is one of the major public health problems both in developed and developing countries. Prison represents a high-risk environment for prisoners, in that it is characterized by high-risk behaviors such as injecting drug use (IDU), tattooing, unprotected sexual intercourses, or sharing syringes. The aim of this study was to quantitatively evaluate the prevalence of HCV among Iranian prisoners conducting a systematic review and meta-analysis. METHODS: We searched different scholarly databases including Embase, PubMed/MEDLINE, ISI/Web of Sciences, the Cochrane library, Scopus, CINAHL, and PsycINFO as well as Iranian bibliographic thesauri (namely, Barakatns, MagIran, and SID) up to December 2017. The Newcastle Ottawa Scale (NOS) was used to assess the quality of the studies included. HCV prevalence rate with its 95% confidence interval (CI) was estimated using the DerSimonian-Laird random-effects model, with Freeman-Tukey double arcsine transformation. Egger’s regression test was used to evaluate publication bias. RESULTS: Finally, 17 articles were selected based on inclusion and exclusion criteria. Overall, 18,693 prisoners were tested. Based on the random-effects model, the prevalence of HCV among Iranian prisoners was 28% (CI 95% 21–36) with heterogeneity of I(2) = 99.3% (p = 0.00). All studies used an ELISA test for the evaluation of HCV antibodies. The findings of this study showed that the highest prevalence rate (53%) was among prisoners who inject drugs. CONCLUSION: The findings of our study showed that the prevalence of HCV among Iranian prisoners is dramatically high. Managing this issue in Iran’s prisons requires careful attention to the availability of health facilities and instruments, such as screening, and harm reduction policies, such as giving sterile syringes and needles to prisoners. An integrated program of training for prisoners, prison personnel and medical staff is also needed to improve the level of health condition in prisons. BioMed Central 2018-05-09 /pmc/articles/PMC5941323/ /pubmed/29739400 http://dx.doi.org/10.1186/s12954-018-0231-0 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Behzadifar, Masoud
Gorji, Hasan Abolghasem
Rezapour, Aziz
Bragazzi, Nicola Luigi
Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysis
title Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysis
title_full Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysis
title_fullStr Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysis
title_full_unstemmed Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysis
title_short Prevalence of hepatitis C virus infection among prisoners in Iran: a systematic review and meta-analysis
title_sort prevalence of hepatitis c virus infection among prisoners in iran: a systematic review and meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941323/
https://www.ncbi.nlm.nih.gov/pubmed/29739400
http://dx.doi.org/10.1186/s12954-018-0231-0
work_keys_str_mv AT behzadifarmasoud prevalenceofhepatitiscvirusinfectionamongprisonersiniranasystematicreviewandmetaanalysis
AT gorjihasanabolghasem prevalenceofhepatitiscvirusinfectionamongprisonersiniranasystematicreviewandmetaanalysis
AT rezapouraziz prevalenceofhepatitiscvirusinfectionamongprisonersiniranasystematicreviewandmetaanalysis
AT bragazzinicolaluigi prevalenceofhepatitiscvirusinfectionamongprisonersiniranasystematicreviewandmetaanalysis